| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/03/2009 | US7485642 Administering levosimendan or a salt thereof |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485626 Biosynthesis of Dna ; cell proliferation; overlapping enzyme activation ; mixture of proteolytic enzyme and dipeptidyl peptidase inhibitors; autoimmune disease; antiinflammatory agents graft versus host diease |
| 02/03/2009 | CA2341397C Immediate release tablet |
| 02/03/2009 | CA2274686C Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/30/2009 | CA2712022A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| 01/29/2009 | WO2009014127A1 Composition for prevention or treatment of disease associated with the production of autoantibody |
| 01/29/2009 | WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1 |
| 01/29/2009 | WO2008107211A3 Novel p2y12 receptor antagonists |
| 01/29/2009 | WO2008049595A9 Trypsin-like serine protease inhibitors, and their preparation and use |
| 01/29/2009 | US20090030075 Remedy for and Method of Treating Ischemic Cerebral Stroke |
| 01/29/2009 | US20090030045 Factor xa inhibitors |
| 01/29/2009 | US20090030034 Use of fgf inhibiting substituted 1,2,3 indolizine derivatives in the preparation of medicaments which can be used to treat diseases linked to pathological choroidal angiogenesis |
| 01/29/2009 | US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/29/2009 | US20090029918 Method for producing mature VWF from VWF Pro-Peptide |
| 01/29/2009 | US20090029444 Novel recombinant anticoagulant proteins |
| 01/29/2009 | US20090029400 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/29/2009 | US20090028880 Serum albumin binding proteins |
| 01/29/2009 | US20090028870 Treatment of Hematologic Disorders |
| 01/28/2009 | EP2018372A2 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor |
| 01/28/2009 | EP2018371A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/28/2009 | EP1372716B1 Blood cell production via activation of cd163 |
| 01/28/2009 | CN101356193A Inhibition of the anti-FVIII immune response |
| 01/28/2009 | CN101355968A Compositions and methods for treating thrombocytopenia |
| 01/28/2009 | CN101352573A Recombinant human granulocyte colony stimulating factor lysine defect body modified by polyethyleneglycol |
| 01/28/2009 | CN101352466A Chinese medicinal composition and uses thereof |
| 01/28/2009 | CN101352436A Novel medicament composition for resisting thrombosis |
| 01/28/2009 | CN101352416A Luteolin solution composition |
| 01/28/2009 | CN101352231A Health care food with function for regulating qi-blood |
| 01/28/2009 | CN101352213A Five-color total nutrient rice and production method |
| 01/28/2009 | CN100455597C Process of high purity albumin production |
| 01/28/2009 | CN100455315C Injecting Mailuoning, its preparation and quality control thereof |
| 01/28/2009 | CN100455283C Medicine containing acarnine compound as active component |
| 01/27/2009 | US7482472 Such as 2-(4-[[(5-chloro-2-thienyl)carbonyl]amino]-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)acetic acid; blood coagulation; treating thromboembolic disorders (myocardial infarction, angina pectoris, reocclusions and restenoses after angioplasty/aortocoronary bypass, stroke), atherosclerosis and arthritis |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482325 Downregulation of immune response by administering B7RP-2 fusion protein |
| 01/27/2009 | US7482024 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/27/2009 | US7482003 Also for treatment of inflammatory bowel disease; humanized heavy/light chains; complementary determining regions |
| 01/27/2009 | CA2540439C Low frequency vibration assisted blood perfusion emergency system |
| 01/27/2009 | CA2415442C Novel .beta. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same |
| 01/27/2009 | CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use |
| 01/27/2009 | CA2332038C Novel pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 01/27/2009 | CA2322633C An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 01/27/2009 | CA2045869C Fusion proteins with immunoglobulin portions, the preparation and use thereof |
| 01/22/2009 | WO2009011889A2 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 01/22/2009 | WO2009011627A1 Pyridine compounds and their use as p2y12 antagonists |
| 01/22/2009 | WO2009011112A1 Stable fat emulsion containing prostaglandin e1 |
| 01/22/2009 | WO2009009952A1 An extract of rehmannia glutinasa libosch. for reducing blood sugar, reducing blood fat, treating leukemia and preparation method and uses thereof |
| 01/22/2009 | WO2008138754A3 New solid forms of fxa inhibitors |
| 01/22/2009 | WO2008116887A3 The use of peritoneal mast cells as a heparin source |
| 01/22/2009 | WO2008076447A3 Treatments of therapy-resistant diseases comprising drug combinations |
| 01/22/2009 | US20090023791 PH-dependent NMDA receptor antagonists |
| 01/22/2009 | US20090023782 Increasing plant vigor |
| 01/22/2009 | US20090023776 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 01/22/2009 | US20090023739 Capase inhibitors and uses thereof |
| 01/22/2009 | US20090023735 Sulphonamide Derivatives |
| 01/22/2009 | US20090023722 Amide substituted imidazoquinolines |
| 01/22/2009 | US20090023686 combining citrate ion source, pyrophosphate ion source, and ferric ion source in water to form a solution, adding an organic solvent to precipitate solid ferric pyrophosphate citrate chelate composition, and isolating citrate chelate having 2% or less phosphate by weight; treating iron deficiency |
| 01/22/2009 | US20090023679 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 01/22/2009 | US20090023670 Regulation of Transgene Expression by RNA Interference |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/22/2009 | US20090023651 Inhibitors of human plasmin derived from the kunitz domains |
| 01/22/2009 | US20090023636 Methods and compositions for the prevention and treatment of anemia |
| 01/22/2009 | US20090023635 Factor VII or VIIa - Like Molecules |
| 01/22/2009 | US20090022804 Chemoembolisation |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022699 Method Of Genotypically Modifying Cells By Administration Of RNA |
| 01/22/2009 | US20090022694 Sirt1 inhibition |
| 01/22/2009 | US20090022669 Compositions for protein delivery via the pulmonary route |
| 01/22/2009 | CA2693590A1 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
| 01/22/2009 | CA2688196A1 Application of polymeric materials to screens to facilitate hemostasis and wound healing |
| 01/21/2009 | EP2017343A2 Protein A based binding domains with desirable activities |
| 01/21/2009 | EP2017338A1 Muscle-specific expression vectors |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016948A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 01/21/2009 | EP2016078A2 Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
| 01/21/2009 | EP2015647A2 Iron complex for use in the treatment and/or prevention of nutritional disorders |
| 01/21/2009 | EP1562939B1 Carboxamides |
| 01/21/2009 | EP1333036B1 Peg-modified erythropoietin |
| 01/21/2009 | EP1307588B1 Method for diagnosing or determining a risk for psychosis comprising determining an heterozygous mutation of methylenetetrahydrofolate reductase (MTHFR) |
| 01/21/2009 | EP0850053B1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/21/2009 | CN101351229A Therapeutic method for blood coagulation disorder |
| 01/21/2009 | CN101351226A Cytotoxic antibodies targeting antibodies inhibiting factor VIII |
| 01/21/2009 | CN101351220A Thrombin-free biological adhesive and use thereof as a medicament |
| 01/21/2009 | CN101351207A Compositions and methods for modulating the immune system |
| 01/21/2009 | CN101348786A Human ª-globin gene and recombinant adeno related viral vector thereof |
| 01/21/2009 | CN101348761A Health care wine |
| 01/21/2009 | CN101348490A Preparation of clopidogrel and salt thereof |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347623A Multifunctional nanodevice platform |
| 01/21/2009 | CN101347593A Decoction medicament for treating haematemesis induced by chronic gastritis |
| 01/21/2009 | CN101347573A Medicament for treating cirrhosis ascites and hepatorenal syndrome and preparation method thereof |
| 01/21/2009 | CN101347529A Compound dual-purpose natto capsules as medicine or food and preparation thereof |
| 01/21/2009 | CN101347470A Glossy privet fruit total triterpenes extract and total phenols extract as well as preparation method thereof |
| 01/21/2009 | CN101347254A Qi-benefitting blood-tonifying drink and method for producing the same |
| 01/21/2009 | CN101347168A Freezing beverage containing ginger sugar juice and method of preparing the same |
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |